1200005I advanced bioscience laboratories; to X17VB--1; optimization of lyophilization and thermal stability of rabies vaccine; base; biod can 8470038; $386,666
Ended Awarded Last action
- Contract number
- HHSN27200017
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $649,142
Award facts
- Contract value 100% obligated
- $649,141.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $10,634 | |
| Other Administrative Action | $72,562 | |
| Original award | $565,946 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The $386,666 contract, which is a task order under a larger indefinite delivery vehicle (IDV), is for the "Optimization of Lyophilization and Thermal Stability of Rabies Vaccine." This work supports the development of medical countermeasures for infectious diseases. ABL is a large, foreign-owned, for-profit organization that specializes in contract research, manufacturing, and development services for vaccines, gene therapies, and other biologics. The contract does not have a set-aside designation. ABL has been awarded multiple IDVs with NIAID, NINDS, and NCI, collectively valued at over $272 million, demonstrating the company's broad capabilities in supporting the federal government's infectious disease and biopharmaceutical research and development initiatives.
Quick answers
Who was awarded contract HHSN27200017?
HHSN27200017 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 9, 2015.
How much is contract HHSN27200017 worth?
The government has obligated $649,142 on HHSN27200017.
Is contract HHSN27200017 an order under another contract?
Yes. HHSN27200017 is a delivery order under HHSN272201200005I, an indefinite delivery contract.
Was contract HHSN27200017 competed?
The extent of competition for HHSN27200017 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award